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THE EXPERIMENTS to be described in
this paper compare the release of soluble
tumour specific transplantation antigens
(TSTA) in vitro from cell lines derived
from two rat sarcomata with widely
differing biological properties. Both are
poorly differentiated fibrosarcomata
induced with methylcholanthrene and
passaged in inbred Hooded (Chester
Beatty) rats with frequent recourse to
stocks maintained in a frozen tumour
bank.
The MC-1 sarcoma is highly immuno-
genic, and immunization of syngeneic
rats with either irradiated cells or amputa-
tion of an established tumour affords
specific protection from a subsequent
challenge with live cells. Spontaneous
metastases to regional lymph nodes or the
lungs are uncommon and surgical cure ofa
subcutaneous transplant of MC-1 in syn-
geneic rats can be readily achieved
(Thomson, Steel and Alexander, 1973c).
The other sarcoma (MC-3) shows quite
different in vivo behaviour (Currie and
Gage, 1973). Immunization of syngeneic
rats with irradiated MC-3 cells does not
afford any resistance to challenge.
Furthermore, attempts to immunize rats
by excision of established tumour invari-
ably fail as metastases to regional nodes
and lungs develop rapidly. It is by
conventional criteria a non-immunogenic
tumour. This inability to immunize with
irradiated cells or tumour amputation does
not necessarily imply that TSTA are
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absent from this tumour. Indeed, Currie
and Gage (1973) have found that specific-
ally cytotoxic lymphoid cells are readily
detectable in the lymph nodes of MC-3-
tumour bearing rats.
The data presented here suggest that
one of the reasons why the normal syn-
geneic host is able to contain the spread
of the MC-1 sarcoma but not the MC-3
may be related to differences in the
release of soluble TSTA from the cells of
these two sarcomata.
Currie and Basham (1972) found in the
serum of patients with disseminated can-
cer, macromolecules of molecular weight
less than 105 daltons which specifically
inhibited the tumour specific cytotoxicity
of peripheral blood mononuclear cells
obtained from the same patients. An
interpretation, consistent with the human
data is that TSTA are released from the
cells of growing tumours and that these
free antigenic determinants eventually
overwhelm any antibody response until in
the later stages of tumour growth a condi-
tion of antigen excess occurs throughout
the extracellular fluid.
In the blood and lymph ofrats bearing
transplanted MC-1 methyleholanthrene
induced sarcomata TSTA activity has been
detected serologically and this disappears
within two days following surgical excision
of the sarcoma (Thomson et al., 1973c;
Thomson, Eccles and Alexander, 1973a;
Thomson et al., 1973b). With the MC-3
sarcoma, Currie and Gage (1973) foundSPONTANEOUS SHEDDING OF TSTA BY VIABLE SARCOMA CELLS
in the serum of tumour bearers a progres-
sive build-up of a factor which inhibited
the cytotoxic action of immune lymphoid
cells directed against MC-3 sarcoma cells
in vitro. The presence in blood of soluble
TSTA from the MC-3 tumour has not
been demonstrated (as was done for the
MC-1 tumour) by the neutralization of
antibody or by radioimmunoassay since a
syngeneic antiserum to this antigen was
not available. Consequently, TSTA acti-
vity was determined in this study by the
test developed by Currie and Basham
(1972) which involves the specific
inhibition of cytotoxic lymphoid cells.
Cultures of MC-1 and MC-3 cells, as
well as of a third Hooded rat sarcoma, the
HSN tumour, which was used as a specifi-
city control, were established from fresh
tumour by trypsinization and cultured in
RPMI 1640 (Biocult) medium containing
10% foetal bovine serum (Flow). The
cultures were grown in plastic bottles and
passaged every 10 days. Cells were used
both for assay and for obtaining super-
natants between the third and tenth
passage. Culture supernatants and sera
were assayed for their capacity to neutral-
ize the specific cytotoxic action of cells
taken from the nodes draining either
MC-1 or MC-3 sarcomata 8 days after
injection of a mechanically prepared
tumour mince, as described by Currie and
Gage (1973). Supernatant medium was
removed from cultures of all 3 sarcomata
24 hours following the previous exchange
of medium. The supernatant media were
filtered through an 0*45 ,tm Millipore
filter and kept frozen until use. These
supernatants were removed from the
cultures during the logarithmic growth
phase before they became confluent.
Following removal of the medium each
culture flask was trypsinized and the
number of tumour cells in each culture
counted in a haemacytometer. Thus, the
24-hour supernatants used for this study
were obtainedfrom 1 * 25 x 106 MC-_1 cells,
0-3 x 106 MC-3 cells or 2-5 X 106 HSN
cells. Sera or culture supernatants were
intheincludedlymphoidcell suspensionsat
1: 20 and the cytotoxicity and inhibition
assavs performed exactly as described by
Currie and Gage (1973). The Table sum-
marizes 4experiments fromwhichit canbe
seen: (1) that the cytotoxicity of lymph
node cellsfromratsbearinganMC-3tumour
for MC-3 cells can be specifically inhibited
by both the serum from MC-3 tumour
bearing rats and the supernatant from
MC-3 cells cultured in vitro; (2) that the
cytotoxicity of lymph node cells from
MC-1 tumour bearing rats for MC-1 cells
is inhibited by the serum from rats
bearing the MC-1 cells but not by the
supernatant from MC-1 cells cultured
in vitro. This result confirms the sero-
logical studies (Thomson et al., 1973a, c)
that had shown that the serum of MC-1
bearing rats contained soluble TSTA.
The important point, however, is that in
vitro release of TSTA from the tumour
cells into the medium can be detected
with the MC-3 cells but not with MC-1
cells. In the case of the MC-1 tumour
Thomson et al. (1973a, b, c) provided
evidence suggestive that the the TSTA
reached the serum either following auto-
lysis of injected tumour cells or as a con-
sequence of immunological attack by an
immunologically competent host but that
there was no evidence for spontaneous
release from living cells. The inability
to find TSTA activity in tissue culture
supernatants of MC-1 cells supports this
view. On the other hand, living MC-3
cells appear to shed TSTA readily since
the TSTA containing supernatants were
derived from cultures in which the cells
were growing logarithmically. There was
no indication of cell death in the cultures
at the time the supernatant was harvested.
It is tempting to correlate the in vivo
behaviour of the MC-3 sarcoma with its
capacity to shed antigen spontaneously.
Metastatic spread may be assisted if
soluble TSTA are discharged from the
cell membrane into the surrounding fluids,
thereby pre-empting the effector limb of
cell mediated immunity. Similarly,
tumours which readily release their TSTA
may after exposure to x-rays lose the
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TABLE I.-Inhibition by Tissue Culture Supernatants and by Serumfrom Tumour
Bearing Rats of Cytotoxic Actions of Immune Lymphoid Cells on Sarcoma Cells
Experimental conditions
A
Lyrnphoid cells
from
Nil
Normal Hooded
lymph nodes
MC-1 tumour
bearing Day 8
MC-1 tumour
bearing Day 8
MC-1 tumour
bearing Day 8
Nil
Normal Hooded
lymph nodes
MC-1 tumour
bearing Day 8
MC-1 tumour
bearing Day 8
MC-1 tumour
bearing Day 8
MC-1 tumour
bearing Day 8
Nil
Normal Hooded
lymph nodes
MC-3 tumour
bearing Day 8
MC-3 tumour
bearing Day 8
MC-3 tumour
bearing Day 8
Nil
Normal Hooded
lymph nodes
MC-3 tumour
bearing Day 8
MC-3 tumour
bearing Day 8
Serum or tissue
Target culture supernatant
cells added
MCI Normal Hooded
serum
MCi Normal Hooded
serum
MCI Normal Hooded
serum
MCI Day 15 MC-1
tumour bearing
serum
MCI MC-1 supernatant
MCI
MCI
MCI
MCI
MCI
MCi
MC3
MC3
MC3
MC3
MC3
MC3
MC3
MC3
MC3
Normal Hooded
serum
Normal Hooded
serum
Control medium
MC-1 supernatant
HSN supernatant
MC-3 supernatant
Normal Hooded
serum
Normal Hooded
serum
Control medium
MC-3 supernatant
HSN supernatant
Normal Hooded
serum
Normal Hooded
serum
Normal Hooded
serum
Day 21 MC-3
tumour bearing
serum
Results
Number of Inhibition of
cells per well Cytotoxicity cytotoxicity
± s.d. (%) (%)
65±2-9 9
69±4- 7 0
23±4-9 65
68±3-1 0 100
27±4- 7
44±4-1
46±4- 8
15±3- 8
20±5-5
20+4- 8
11i3- 7
123±4-4
129±5- 6
65+7-1
122±3 - 7
75±7-4
202±9 - 2
201±8-7
109±20
187±14
59
0
61
55
55
75
0
47
1
39
0
46
8
9.5
17-2
17-2
0
98-4
17-1
84
capacity to immunize because the concen-
tration of membrane bound TSTA falls.
The fact that the serum activities of
circulating TSTA appear to be similar
for rats with a growing MC-3 and an
MC-1 tumour suggests that the biologic-
ally important role of circulating TSTA
may be in the micro-environment in which
disseminated tumour cells lodge rather
than in the blood. A similar conclusion
can be drawn from Currie's (1973) finding
that following surgical removal of mela-
noma and hypernephroma the level of
inhibitor (i.e. soluble TSTA) in the blood
disappears, yet metastatic recurrence of
disease following surgery is unfortunately
frequent.
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